Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust RBA American Industrial Renaissance UCITS ETF 14.10.2026 AIRR LN IE000U6ABUJ7 9,500,002.00 USD 229,965,076.55   24.207  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Nasdaq Clean Edge Global Water UCITS ETF 14.10.2026 H2O LN IE000Q8F0M81  700,002.00 USD  13,936,149.26   19.909  ...

SAN FRANCISCO--(BUSINESS WIRE)--Angle Health, the first vertically integrated AI platform for healthcare benefits, and Transcarent, the first agentic AI-powered health and care platform, today announced a partnership to give Angle Health members greater access to high quality, comprehensive and coordinated MSK (musculoskeletal) and surgical care. Beginning January 1, 2027, Angle Health members will have access to Transcarent's integrated care offering through the partnership. This partnership b...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100 Moderate Buffer UCITS ETF - June 14.10.2026 QJUN.LN IE000HFBJ0U0 4,800,002.00 USD 109,329,865.67   22.777  ...

DALLAS--(BUSINESS WIRE)--The Mary Kay Ash Foundation® announces it has awarded over $2.5 million in cancer research and domestic violence shelter grants around the country....

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the third quarter ending September 30, 2026 on Thursday, October 29, 2026, before the U.S. financial markets open. Management will provide an update on the Company and discuss third quarter 2026 results as well as expectations for the future via conference call on Thursday, October 29, 2026 at 8:30 am ET. A live audio w...

WALTHAM, Mass.--(BUSINESS WIRE)--CellTivity Scientific, a leader in point-of-care tissue assessment, announced that its Van Gogh Microscopy System has now been utilized in more than 10,000 patient procedures, marking an important milestone as adoption of the company’s Dynamic Cell Imaging™ technology continues to grow in the U.S. and internationally.CellTivity’s Van Gogh Microscopy System provides metabolic cellular imaging designed to support timely, intraprocedural tissue assessment and decisi...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ankyra Therapeutics, a clinical-stage biotechnology company pioneering anchored immunotherapy to deliver better outcomes for people with cancer and other serious diseases, announced that three abstracts, including an oral presentation, will be featured at the 2026 Society for Immunotherapy of Cancer (SITC) Annual Meeting, taking place November 4-8 in Phoenix, AZ. The three accepted abstracts focus on preclinical data demonstrating how Ankyra’s anchored immunot...

SAN JOSE, Calif.--(BUSINESS WIRE)--Momentus Inc. (NASDAQ: MNTS) (“Momentus” or the “Company”), a U.S. commercial space company specializing in satellite technology, space transportation, and in-orbit services, today announced it has expanded its commercial business portfolio and entered into a contract with ARCSPACE, an aerospace company specializing in in-space servicing, assembly, and manufacturing (ISAM). Momentus will host ARCSPACE’s payload focused on space manufacturing through an autonomo...

PROVO, Utah--(BUSINESS WIRE)--Study from Green Dot finds 9 in 10 leaders plan to increase embedded finance investments despite uncertainty around security, regulation, agentic AI...